The impact of viral evolution and frequency of variant epitopes on primary and memory human immunodeficiency virus type 1-specific CD8+ T cell responses

Virology

Volumn 450-451, Issue , 2014, Pages 34-48

  Melhem, Nada M ^a   Smith, Kellie N ^b   Huang, Xiao Li ^c   Colleton, Bonnie A ^d   Jiang, Weimin ^c   Mailliard, Robbie B ^c   Mullins, James I ^e   Rinaldo, Charles R ^c  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Autologous viral variants; CART; HIV 1; Memory T cell responses; Primary T cell responses

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CD8 ANTIGEN; EFAVIRENZ; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EPITOPE; LAMIVUDINE; NELFINAVIR; SAQUINAVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOREACTIVITY; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION;

AUTOLOGOUS VIRAL VARIANTS; CART; HIV-1; MEMORY T CELL RESPONSES; PRIMARY T CELL RESPONSES;

ADULT; ANTI-HIV AGENTS; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; EPITOPES, T-LYMPHOCYTE; EVOLUTION, MOLECULAR; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HUMANS; MALE; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 84890810921     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.10.015     Document Type: Article

References (70)

1. Addo M.M., Yu X.G., Rathod A., Cohen D., Eldridge R.L., Strick D., Johnston M.N., Corcoran C., Wurcel A.G., Fitzpatrick C.A., Feeney M.E., Rodriguez W.R., Basgoz N., Draenert R., Stone D.R., Brander C., Goulder P.J., Rosenberg E.S., Altfeld M., Walker B.D. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 2003, 77(3):2081-2092.
2. Allen T.M., Altfeld M., Yu X.G., O'Sullivan K.M., Lichterfeld M., Le Gall S., John M., Mothe B.R., Lee P.K., Kalife E.T., Cohen D.E., Freedberg K.A., Strick D.A., Johnston M.N., Sette A., Rosenberg E.S., Mallal S.A., Goulder P.J., Brander C., Walker B.D. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J. Virol. 2004, 78(13):7069-7078.
3. Allen T.M., Jing P., Calore B., Horton H., O'Connor D.H., Hanke T., Piekarczyk M., Ruddersdorf R., Mothe B.R., Emerson C., Wilson N., Lifson J.D., Belyakov I.M., Berzofsky J.A., Wang C., Allison D.B., Montefiori D.C., Desrosiers R.C., Wolinsky S., Kunstman K.J., Altman J.D., Sette A., McMichael A.J., Watkins D.I. Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection. J. Virol. 2002, 76(20):10507-10511.
4. Allen T.M., O'Connor D.H., Jing P., Dzuris J.L., Mothe B.R., Vogel T.U., Dunphy E., Liebl M.E., Emerson C., Wilson N., Kunstman K.J., Wang X., Allison D.B., Hughes A.L., Desrosiers R.C., Altman J.D., Wolinsky S.M., Sette A., Watkins D.I. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 2000, 407(6802):386-390.
5. Appay V., Douek D.C., Price D.A. CD8+ T cell efficacy in vaccination and disease. Nat. Med. 2008, 14(6):623-628.
6. Baker B.M., Block B.L., Rothchild A.C., Walker B.D. Elite control of HIV infection: implications for vaccine design. Expert Opin. Biol. Ther. 2009, 9(1):55-69.
7. Bangham C.R. CTL quality and the control of human retroviral infections. Eur. J. Immunol. 2009, 39(7):1700-1712.
8. Barouch D.H., Korber B. HIV-1 vaccine development after STEP. Annu. Rev. Med. 2010, 61:153-167.
9. Barouch D.H., McKay P.F., Sumida S.M., Santra S., Jackson S.S., Gorgone D.A., Lifton M.A., Chakrabarti B.K., Xu L., Nabel G.J., Letvin N.L. Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines. J. Virol. 2003, 77(16):8729-8735.
10. Berger C.T., Frahm N., Price D.A., Mothe B., Ghebremichael M., Hartman K.L., Henry L.M., Brenchley J.M., Ruff L.E., Venturi V., Pereyra F., Sidney J., Sette A., Douek D.C., Walker B.D., Kaufmann D.E., Brander C. High-functional-avidity cytotoxic t lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control. J. Virol. 2011, 85(18):9334-9345.
11. Bihl F., Frahm N., Di Giammarino L., Sidney J., John M., Yusim K., Woodberry T., Sango K., Hewitt H.S., Henry L., Linde C.H., Chisholm J.V., Zaman T.M., Pae E., Mallal S., Walker B.D., Sette A., Korber B.T., Heckerman D., Brander C. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J. Immunol. 2006, 176(7):4094-4101.
12. Borrow P., Lewicki H., Wei X., Horwitz M.S., Peffer N., Meyers H., Nelson J.A., Gairin J.E., Hahn B.H., Oldstone M.B., Shaw G.M. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 1997, 3(2):205-211.
13. Buchli R., VanGundy R.S., Hickman-Miller H.D., Giberson C.F., Bardet W., Hildebrand W.H. Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*LA-Aopment and validation of a fluores. Biochemistry 2005, 44(37):12491-12507.
14. Buseyne F., Riviere Y. The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes. Int. Immunol. 2001, 13(7):941-950.
15. Casazza J.P., Betts M.R., Hill B.J., Brenchley J.M., Price D.A., Douek D.C., Koup R.A. Immunologic pressure within class I-restricted cognate human immunodeficiency virus epitopes during highly active antiretroviral therapy. J. Virol. 2005, 79(6):3653-3663.
16. Chen H., Ndhlovu Z.M., Liu D., Porter L.C., Fang J.W., Darko S., Brockman M.A., Miura T., Brumme Z.L., Schneidewind A., Piechocka-Trocha A., Cesa K.T., Sela J., Cung T.D., Toth I., Pereyra F., Yu X.G., Douek D.C., Kaufmann D.E., Allen T.M., Walker B.D. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat. Immunol. 2012, 13(7):691-700.
17. Colleton B.A., Huang X.L., Melhem N.M., Fan Z., Borowski L., Rappocciolo G., Rinaldo C.R. Primary human immunodeficiency virus type 1-specific CD8+ T-cell responses induced by myeloid dendritic cells. J. Virol. 2009, 83(12):6288-6299.
18. Corbeau P., Reynes J. Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection. Blood 2011, 117(21):5582-5590.
19. Corey L., McElrath M.J., Kublin J.G. Post-step modifications for research on HIV vaccines. AIDS 2009, 23(1):3-8.
20. Davenport M.P., Price D.A., McMichael A.J. The T cell repertoire in infection and vaccination: implications for control of persistent viruses. Curr. Opin. Immunol. 2007, 19(3):294-300.
21. Deeks S.G., Walker B.D. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007, 27(3):406-416.
22. Detels R., Jacobson L., Margolick J., Martinez-Maza O., Munoz A., Phair J., Rinaldo C., Wolinsky S. The multicenter AIDS cohort study. Public Health 2012, 126(3):196-198.
23. Draenert R., Le Gall S., Pfafferott K.J., Leslie A.J., Chetty P., Brander C., Holmes E.C., Chang S.C., Feeney M.E., Addo M.M., Ruiz L., Ramduth D., Jeena P., Altfeld M., Thomas S., Tang Y., Verrill C.L., Dixon C., Prado J.G., Kiepiela P., Martinez-Picado J., Walker B.D., Goulder P.J. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J. Exp. Med. 2004, 199(7):905-915.
24. Fan Z., Huang X.L., Kalinski P., Young S., Rinaldo C.R. Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection. Clin. Vaccine Immunol. 2007, 14(9):1127-1137.
25. Frahm N., Korber B.T., Adams C.M., Szinger J.J., Draenert R., Addo M.M., Feeney M.E., Yusim K., Sango K., Brown N.V., SenGupta D., Piechocka-Trocha A., Simonis T., Marincola F.M., Wurcel A.G., Stone D.R., Russell C.J., Adolf P., Cohen D., Roach T., StJohn A., Khatri A., Davis K., Mullins J., Goulder P.J., Walker B.D., Brander C. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J. Virol. 2004, 78(5):2187-2200.
26. Giorgi J.V., Cheng H.L., Margolick J.B., Bauer K.D., Ferbas J., Waxdal M., Schmid I., Hultin L.E., Jackson A.L., Park L., et al. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group. Clin. Immunol. Immunopathol. 1990, 55(2):173-186.
27. Goulder P.J., Watkins D.I. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat. Rev. Immunol. 2008, 8(8):619-630.
28. Hoof I., Peters B., Sidney J., Pedersen L.E., Sette A., Lund O., Buus S., Nielsen M. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 2009, 61(1):1-13.
29. Huang X.L., Fan Z., Borowski L., Rinaldo C.R. Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8(+) T cell immunity. J. Leukoc. Biol. 2008, 83(6):1530-1540.
30. Janbazian L., Price D.A., Canderan G., Filali-Mouhim A., Asher T.E., Ambrozak D.R., Scheinberg P., Boulassel M.R., Routy J.P., Koup R.A., Douek D.C., Sekaly R.P., Trautmann L. Clonotype and repertoire changes drive the functional improvement of HIV-specific CD8 T cell populations under conditions of limited antigenic stimulation. J. Immunol. 2012, 188(3):1156-1167.
31. Jones N.A., Wei X., Flower D.R., Wong M., Michor F., Saag M.S., Hahn B.H., Nowak M.A., Shaw G.M., Borrow P. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J. Exp. Med. 2004, 200(10):1243-1256.
32. Kalams S.A., Goulder P.J., Shea A.K., Jones N.G., Trocha A.K., Ogg G.S., Walker B.D. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J. Virol. 1999, 73(8):6721-6728.
33. Kaslow R.A., Ostrow D.G., Detels R., Phair J.P., Polk B.F., Rinaldo C.R. The multicenter AIDS cohort study: rationale, organization, and selected characteristics of the participants. Am. J. Epidemiol. 1987, 126(2):310-318.
34. Kiepiela P., Ngumbela K., Thobakgale C., Ramduth D., Honeyborne I., Moodley E., Reddy S., de Pierres C., Mncube Z., Mkhwanazi N., Bishop K., van der Stok M., Nair K., Khan N., Crawford H., Payne R., Leslie A., Prado J., Prendergast A., Frater J., McCarthy N., Brander C., Learn G.H., Nickle D., Rousseau C., Coovadia H., Mullins J.I., Heckerman D., Walker B.D., Goulder P. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 2007, 13(1):46-53.
35. Koup R.A., Safrit J.T., Cao Y., Andrews C.A., McLeod G., Borkowsky W., Farthing C., Ho D.D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 1994, 68(7):4650-4655.
36. Ladell K., Hashimoto M., Iglesias M.C., Wilmann P.G., McLaren J.E., Gras S., Chikata T., Kuse N., Fastenackels S., Gostick E., Bridgeman J.S., Venturi V., Arkoub Z.A., Agut H., van Bockel D.J., Almeida J.R., Douek D.C., Meyer L., Venet A., Takiguchi M., Rossjohn J., Price D.A., Appay V. A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells. Immunity 2013, 38(3):425-436.
37. Leslie A.J., Pfafferott K.J., Chetty P., Draenert R., Addo M.M., Feeney M., Tang Y., Holmes E.C., Allen T., Prado J.G., Altfeld M., Brander C., Dixon C., Ramduth D., Jeena P., Thomas S.A., John A., Roach T.A., Kupfer B., Luzzi G., Edwards A., Taylor G., Lyall H., Tudor-Williams G., Novelli V., Martinez-Picado J., Kiepiela P., Walker B.D., Goulder P.J. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 2004, 10(3):282-289.
38. Liu J., O'Brien K.L., Lynch D.M., Simmons N.L., La Porte A., Riggs A.M., Abbink P., Coffey R.T., Grandpre L.E., Seaman M.S., Landucci G., Forthal D.N., Montefiori D.C., Carville A., Mansfield K.G., Havenga M.J., Pau M.G., Goudsmit J., Barouch D.H. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 2009, 457(7225):87-91.
39. Liu Y., McNevin J., Cao J., Zhao H., Genowati I., Wong K., McLaughlin S., McSweyn M.D., Diem K., Stevens C.E., Maenza J., He H., Nickle D.C., Shriner D., Holte S.E., Collier A.C., Corey L., McElrath M.J., Mullins J.I. Selection on the human immunodeficiency virus type 1 proteome following primary infection. J. Virol. 2006, 80(19):9519-9529.
40. Liu Y., McNevin J., Zhao H., Tebit D.M., Troyer R.M., McSweyn M., Ghosh A.K., Shriner D., Arts E.J., McElrath M.J., Mullins J.I. Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape. J. Virol. 2007, 81(22):12179-12188.
41. Liu Y., McNevin J.P., Holte S., McElrath M.J., Mullins J.I. Dynamics of viral evolution and CTL responses in HIV-1 infection. PLoS One 2011, 6(1):e15639.
42. Malaspina, A., Rinaldo, C.R., Sekaly, R.P., Flores, J., and D'Souza, P.M. (2011). In vitro systems to characterize the immune response to HIV-1 and HIV-1 vaccine candidates, NIAID Workshop Report, Bethesda, August 4, 2010. Vaccine 29(29-30), pp. 4647-4653.
43. Malhotra U., Li F., Nolin J., Allison M., Zhao H., Mullins J.I., Self S., McElrath M.J. Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection. J. Virol. 2007, 81(10):5225-5237.
44. McElrath M.J., De Rosa S.C., Moodie Z., Dubey S., Kierstead L., Janes H., Defawe O.D., Carter D.K., Hural J., Akondy R., Buchbinder S.P., Robertson M.N., Mehrotra D.V., Self S.G., Corey L., Shiver J.W., Casimiro D.R. HIV-1 vaccine-induced immunity in the test-of-concept step study: a case-cohort analysis. Lancet 2008, 372(9653):1894-1905.
45. Nielsen M., Lundegaard C., Blicher T., Lamberth K., Harndahl M., Justesen S., Roder G., Peters B., Sette A., Lund O., Buus S. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One 2007, 2(8):e796.
46. O'Connor D.H., Allen T.M., Vogel T.U., Jing P., DeSouza I.P., Dodds E., Dunphy E.J., Melsaether C., Mothe B., Yamamoto H., Horton H., Wilson N., Hughes A.L., Watkins D.I. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat. Med. 2002, 8(5):493-499.
47. Pandrea I., Gaufin T., Gautam R., Kristoff J., Mandell D., Montefiori D., Keele B.F., Ribeiro R.M., Veazey R.S., Apetrei C. Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T cells and is reverted by CD8+ cell depletion. PLoS Pathog. 2011, 7(8):e1002170.
48. Parker K.C., Bednarek M.A., Coligan J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 1994, 152(1):163-175.
49. Price D.A., West S.M., Betts M.R., Ruff L.E., Brenchley J.M., Ambrozak D.R., Edghill-Smith Y., Kuroda M.J., Bogdan D., Kunstman K., Letvin N.L., Franchini G., Wolinsky S.M., Koup R.A., Douek D.C. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 2004, 21(6):793-803.
50. Prlic M., Williams M.A., Bevan M.J. Requirements for CD8 T-cell priming, memory generation and maintenance. Curr. Opin. Immunol. 2007, 19(3):315-319.
51. Reynolds M.R., Weiler A.M., Weisgrau K.L., Piaskowski S.M., Furlott J.R., Weinfurter J.T., Kaizu M., Soma T., Leon E.J., MacNair C., Leaman D.P., Zwick M.B., Gostick E., Musani S.K., Price D.A., Friedrich T.C., Rakasz E.G., Wilson N.A., McDermott A.B., Boyle R., Allison D.B., Burton D.R., Koff W.C., Watkins D.I. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J. Exp. Med. 2008, 205(11):2537-2550.
52. Rinaldo C.R. Dendritic cell-based human immunodeficiency virus vaccine. J. Intern. Med. 2009, 265(1):138-158.
53. Rinaldo C.R., Huang X.L., Fan Z., Margolick J.B., Borowski L., Hoji A., Kalinyak C., McMahon D.K., Riddler S.A., Hildebrand W.H., Day R.B., Mellors J.W. Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency. J. Virol. 2000, 74(9):4127-4138.
54. Rolland M., Heckerman D., Deng W., Rousseau C.M., Coovadia H., Bishop K., Goulder P.J., Walker B.D., Brander C., Mullins J.I. Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads. PLoS One 2008, 3(1):e1424.
55. Rosario M., Bridgeman A., Quakkelaar E.D., Quigley M.F., Hill B.J., Knudsen M.L., Ammendola V., Ljungberg K., Borthwick N., Im E.J., McMichael A.J., Drijfhout J.W., Greenaway H.Y., Venturi V., Douek D.C., Colloca S., Liljestrom P., Nicosia A., Price D.A., Melief C.J., Hanke T. Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques. Eur. J. Immunol. 2010, 40(7):1973-1984.
56. Saez-Cirion A., Lacabaratz C., Lambotte O., Versmisse P., Urrutia A., Boufassa F., Barre-Sinoussi F., Delfraissy J.F., Sinet M., Pancino G., Venet A. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc. Natl. Acad. Sci. USA 2007, 104(16):6776-6781.
57. Schenker E.L., Hultin L.E., Bauer K.D., Ferbas J., Margolick J.B., Giorgi J.V. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program. Cytometry 1993, 14(3):307-317.
58. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., Racz P., Tenner-Racz K., Dalesandro M., Scallon B.J., Ghrayeb J., Forman M.A., Montefiori D.C., Rieber E.P., Letvin N.L., Reimann K.A. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999, 283(5403):857-860.
59. Schneider, E., Whitmore, S., Glynn, K.M., Dominguez, K., Mitsch, A., and McKenna, M.T. 2008. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years-United States, 2008. MMWR Recomm. Rep. 57(RR-10), pp. 1-12.
60. Shankarappa R., Margolick J.B., Gange S.J., Rodrigo A.G., Upchurch D., Farzadegan H., Gupta P., Rinaldo C.R., Learn G.H., He X., Huang X.L., Mullins J.I. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 1999, 73(12):10489-10502.
61. Shin H., Blackburn S.D., Blattman J.N., Wherry E.J. Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. J. Exp. Med. 2007, 204(4):941-949.
62. Shriner D., Rodrigo A.G., Nickle D.C., Mullins J.I. Pervasive genomic recombination of HIV-1 in vivo. Genetics 2004, 167(4):1573-1583.
63. Tenzer S., Wee E., Burgevin A., Stewart-Jones G., Friis L., Lamberth K., Chang C.H., Harndahl M., Weimershaus M., Gerstoft J., Akkad N., Klenerman P., Fugger L., Jones E.Y., McMichael A.J., Buus S., Schild H., van Endert P., Iversen A.K. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat. Immunol. 2009, 10(6):636-646.
64. Turnbull E.L., Wong M., Wang S., Wei X., Jones N.A., Conrod K.E., Aldam D., Turner J., Pellegrino P., Keele B.F., Williams I., Shaw G.M., Borrow P. Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection. J. Immunol. 2009, 182(11):7131-7145.
65. van Bockel D.J., Price D.A., Munier M.L., Venturi V., Asher T.E., Ladell K., Greenaway H.Y., Zaunders J., Douek D.C., Cooper D.A., Davenport M.P., Kelleher A.D. Persistent survival of prevalent clonotypes within an immunodominant HIV gag-specific CD8+ T cell response. J. Immunol. 2011, 186(1):359-371.
66. Vezys V., Masopust D., Kemball C.C., Barber D.L., O'Mara L.A., Larsen C.P., Pearson T.C., Ahmed R., Lukacher A.E. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J. Exp. Med. 2006, 203(10):2263-2269.
67. Wherry E.J., Barber D.L., Kaech S.M., Blattman J.N., Ahmed R. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc. Natl. Acad. Sci. USA 2004, 101(45):16004-16009.
68. Yokomaku Y., Miura H., Tomiyama H., Kawana-Tachikawa A., Takiguchi M., Kojima A., Nagai Y., Iwamoto A., Matsuda Z., Ariyoshi K. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection. J. Virol. 2004, 78(3):1324-1332.
69. Yusim S., Szinger J.J., Honeyborne I., Calef C., Goulder P.J., Korber B.T. Enhanced motif scan: a tool to scan for HLA anchor residues in proteins. HIV Immunology and HIV/SIV Vaccine Databases 2003 2004, 25-36. Published by: Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, New Mexico, (LA-UR 04-8162). B.T. Korber, C. Brander, B.F. Haynes, R. Koup, J.P. Moore, B.D. Walker, D.I. Watkins (Eds.).
70. Zehn D., Lee S.Y., Bevan M.J. Complete but curtailed T-cell response to very low-affinity antigen. Nature 2009, 458(7235):211-214.